<SEC-DOCUMENT>0001683168-18-003125.txt : 20181024
<SEC-HEADER>0001683168-18-003125.hdr.sgml : 20181024
<ACCEPTANCE-DATETIME>20181024075522
ACCESSION NUMBER:		0001683168-18-003125
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20181022
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20181024
DATE AS OF CHANGE:		20181024

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SIMULATIONS PLUS INC
		CENTRAL INDEX KEY:			0001023459
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
		IRS NUMBER:				954595609
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32046
		FILM NUMBER:		181135292

	BUSINESS ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
		BUSINESS PHONE:		661-723-7723

	MAIL ADDRESS:	
		STREET 1:		42505 10TH STREET WEST
		CITY:			LANCASTER
		STATE:			CA
		ZIP:			93534-7059
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>simulations_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">UNITED STATES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SECURITIES AND EXCHANGE COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">WASHINGTON, D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CURRENT REPORT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">October 22, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Date
of the earliest event reported)</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt">Simulations
Plus, Inc.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Exact
name of registrant as specified in its charter)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 34%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">California</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">001-32046</FONT></TD>
    <TD STYLE="width: 33%; font-weight: bold; text-align: center">95-4595609</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(State or other jurisdiction of incorporation)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(Commission File Number)</FONT></TD>
    <TD STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-weight: normal">(I.R.S. Employer Identification No.)</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">42505 10<SUP>th</SUP> Street West,
Lancaster, California 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">(Address
of principal executive offices) (Zip Code)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">661-723-7723</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-weight: normal">Registrant's
telephone number, including area code</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">Check the appropriate box
below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
provisions:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-weight: normal">[_] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-weight: normal">[_] Soliciting material pursuant to Rule 14z-12 under Exchange Act (17 CFR 240.14a-12) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-weight: normal">[_] Pre-commencement communications pursuant to Rule 14d-2(b) under Exchange Act (17 CFR 240.14d-2(b)) </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in"><FONT STYLE="font-weight: normal">[_] Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e-4(c))</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">Indicate by check mark whether
the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&sect;230.405 of this chapter)
or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter). &#9;Emerging Growth Company [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [_]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo; Options: Hidden -->&nbsp;<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 14.25pt; text-indent: -14.25pt">&nbsp;</P>


<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 7.01</B></TD><TD><B>Regulation FD Disclosure</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On October 22, 2018, Simulations Plus,
Inc., a California corporation (the &quot;Company&quot;), issued a press release announcing that its board of directors has declared
a quarterly cash dividend of $0.06 per share of common stock, payable on November 8, 2018 to shareholders of record on November
1, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">A copy of press release is attached hereto
as Exhibit 99.1 and incorporated herein by reference.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The information contained in this Current
Report on Form 8-K shall not be deemed to be &quot;filed&quot; for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the &quot;Exchange Act&quot;), or otherwise subject to the liabilities of that section, nor shall such information
be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the &quot;Securities Act&quot;),
or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing. The information set forth in
this Current Report on Form 8-K shall not be deemed an admission as to the materiality of any information in this report on Current
Report on Form 8-K that is required to be disclosed solely to satisfy the requirements of Regulation FD.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Current Report on Form 8-K may contain
forward-looking statements that are made pursuant to the safe harbor provisions of Section 21E of the Exchange Act. The forward-looking
statements in this Current Report on Form 8-K are not historical facts, do not constitute guarantees of future performance and
are based on numerous assumptions which, while believed to be reasonable, may not prove to be accurate. Any forward-looking statements
in this Current Report on Form 8-K do not constitute guarantees of future performance and involve a number of factors that could
cause actual results to differ materially, including risks more fully described in our most recently filed Quarterly Report on
Form 10-Q and Annual Report on Form 10-K. The Company assumes no obligation to update any forward-looking information contained
in this Current Report or with respect to the announcements described herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in"><B>Item 9.01</B></TD><TD><B>Financial Statements and Exhibits</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exhibits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.75in">99.1</TD><TD><A HREF="simulations_ex9901.htm">Press release issued on October 22, 2018.</A></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt">&nbsp;</DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SIGNATURES</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<TABLE BORDER="0" CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">SIMULATIONS PLUS, INC.</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
<TR>
    <TD STYLE="vertical-align: top; width: 50%">Dated: October 24, 2018</TD>
    <TD STYLE="width: 4%">By:&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 46%">/s/ /s/ John R. Kneisel</TD></TR>
<TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-top: #000000 1px solid">John R. Kneisel<BR>Chief Financial Officer</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: 0pt; margin-top: 0pt; margin-bottom: 6pt"></P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>simulations_ex9901.htm
<DESCRIPTION>PRESS RELEASE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">Exhibit 99.1</P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="image_001.gif" ALT="" STYLE="height: 38px; width: 213px"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Further Information:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">42505 10<SUP>th</SUP> Street West</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lancaster, CA 93534-7059</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 39%"><FONT STYLE="font-size: 10pt"><B>CONTACT</B>:</FONT></TD>
    <TD STYLE="width: 28%">&nbsp;</TD>
    <TD STYLE="width: 33%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt"><U>Simulations Plus Investor Relations</U></FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt"><U>Hayden IR</U></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">Ms. Renee Bouche</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Mr. Cameron Donahue</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">661-723-7723</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">651-653-1854</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-size: 10pt">renee@simulations-plus.com</FONT></TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">cameron@haydenir.com</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For Immediate Release:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">October 22, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Simulations Plus Announces Quarterly
Cash Dividend of $0.06 per Share</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>LANCASTER, CA, October 22, 2018 &ndash;
</B>Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology,
chemicals, and consumer goods industries, today announced that its board of directors has declared its next ongoing quarterly cash
dividend of $0.06 per share of the Company&rsquo;s common stock. The cash dividend will be distributed on Thursday, November 8,
2018, to shareholders of record as of Thursday, November 1, 2018.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Walt Woltosz, chairman of the board of
directors, said, &ldquo;This dividend declaration is a continuation of the Board&rsquo;s plan to distribute a cash dividend of
$0.06 per share per quarter. The declaration of any future dividends will be determined by the board of directors each quarter
and will depend on earnings, financial condition, capital requirements, and other factors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>About Simulations Plus, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Simulations Plus, Inc., is a premier developer
of drug discovery and development software as well as a leading provider of both preclinical and clinical pharmacometric <FONT STYLE="color: blue">consulting
services</FONT> for regulatory submissions and <FONT STYLE="color: blue">quantitative systems pharmacology models</FONT> for drug-induced
liver injury and <FONT STYLE="color: blue">nonalcoholic fatty liver disease</FONT>. The company is a global leader focused on improving
the ways scientists use knowledge and data to predict the properties and outcomes of pharmaceutical, biotechnology, and chemical
agents. Our software is licensed to and used in the conduct of drug research by major pharmaceutical, biotechnology, chemical,
and consumer goods companies and regulatory agencies worldwide. Our innovations in integrating new and existing science in medicinal
chemistry, computational chemistry, pharmaceutical science, biology, and physiology into our software have made us the leading
software provider for physiologically based pharmacokinetic modeling and simulation. For more information, visit our website at
<FONT STYLE="color: blue">www.simulations-plus.com</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">###</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.gif
M1TE&.#=AU0 F '<  "'^&E-O9G1W87)E.B!-:6-R;W-O9G0@3V9F:6-E "P
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MN,9_OO!38([K5#B%V%VN9[&70^5 'P@QRJ$ *D2Z'AD@A@8<'?FZ3T3K'H&
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:BJB8BJKX%/ZWBJ[XBK 8B[(XB[3X%0$! #L!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
